Removal of the primary tumor in hematogenous metastatic tumor disease

被引：0

作者：

Huber, J. ^{[1
]}

Groeben, C. ^{[1
]}

Wirth, M. P. ^{[1
]}

机构：

[1] Tech Univ Dresden, Klin & Poliklin Urol, Med Fak Carl Gustav Carus, D-01307 Dresden, Germany

来源：

UROLOGE | 2014年 / 53卷 / 06期

关键词：

Cytoreductive surgery; Survival; Quality of life; Prostate cancer; Renal cell cancer; RENAL-CELL CARCINOMA; FACTOR-TARGETED THERAPY; CYTOREDUCTIVE NEPHRECTOMY; RADICAL PROSTATECTOMY; LOCAL TREATMENT; SURVIVAL; CANCER; IMPACT;

D O I：

10.1007/s00120-014-3548-7

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Primarily treating metastatic malignancies systemically was an untouchable dogma for decades. Accordingly local therapy was reserved for localized disease only. However, in some oncological entities this apodictic principle could be disproved. In metastatic renal cell carcinoma cytoreductive nephrectomy is the current standard of care for appropriately selected patients but there is a lack of robust data for radical prostatectomy in patients with hematogenous spread from prostate cancer. Therefore, surgical treatment is not recommended outside clinical trials for the latter indication.

引用

页码：840 / +

页数：5

共 22 条

[1] Better survival in patients with metastasised kidney cancer after nephrectomy: A population-based study in the Netherlands [J].

Aben, K. K. H. ;

Heskamp, S. ;

Janssen-Heijnen, M. L. ;

Koldewijn, E. L. ;

van Herpen, C. M. ;

Kiemeney, L. A. ;

Oosterwijk, E. ;

van Spronsen, D. J. .

EUROPEAN JOURNAL OF CANCER, 2011, 47 (13) :2023-2032

[2]

[Anonymous], INTERDISZIPLINARE LE

[3] Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy [J].

Barbastefano, Juan ;

Garcia, Jorge A. ;

Elson, Paul ;

Wood, Laura S. ;

Lane, Brian R. ;

Dreicer, Robert ;

Campbell, Steven C. ;

Rini, Brian I. .

BJU INTERNATIONAL, 2010, 106 (09) :1266-1269

[4]

Bex A, 2012, EXPERT REV ANTICANC, V12, P787, DOI [10.1586/era.12.54, 10.1586/ERA.12.54]

[5] Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].

Bristow, RE ;

Tomacruz, RS ;

Armstrong, DK ;

Trimble, EL ;

Montz, FJ .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259

[6] Laparoscopic Radical Prostatectomy Demonstrates Less Morbidity Than Open Radical Prostatectomy: An Analysis of the American College of Surgeons-National Surgical Quality Improvement Program Database with a Focus on Surgical Trainee Involvement [J].

Caras, Ronald J. ;

Lustik, Michael B. ;

Kern, Sean Q. ;

Sterbis, Joseph R. ;

McMann, Leah P. .

JOURNAL OF ENDOUROLOGY, 2014, 28 (03) :298-305

[7] The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy [J].

Choueiri, Toni K. ;

Xie, Wanling ;

Kollmannsberger, Christian ;

North, Scott ;

Knox, Jennifer J. ;

Lampard, J. Geoffrey ;

McDermott, David F. ;

Rini, Brian I. ;

Heng, Daniel Y. C. .

JOURNAL OF UROLOGY, 2011, 185 (01) :60-66

[8] Clinical implications of cancer self-seeding [J].

Comen, Elizabeth ;

Norton, Larry ;

Massague, Joan .

NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (06) :369-377

[9] Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study [J].

Culp, Stephen H. ;

Schellhammer, Paul F. ;

Williams, Michael B. .

EUROPEAN UROLOGY, 2014, 65 (06) :1058-1066

[10] Survival Benefit of Radical Prostatectomy in Lymph Node-Positive Patients with Prostate Cancer [J].

Engel, Jutta ;

Bastian, Patrick J. ;

Baur, Helmut ;

Beer, Volker ;

Chaussy, Christian ;

Gschwend, Juergen E. ;

Oberneder, Ralph ;

Rothenberger, Karl H. ;

Stief, Christian G. ;

Hoelzel, Dieter .

EUROPEAN UROLOGY, 2010, 57 (05) :754-761

← 1 2 3 →